Hartman Institute for Therapeutic Organ Regeneration

Publications

Found 7 results
Author Title Type [ Year(Asc)]
Filters: Keyword is Angiogenesis Inhibitors  [Clear All Filters]
2014
Poulos MG, Gars EJ, Gutkin MC, Kloss CC, Ginsberg M, Scandura JM, Rafii S, Butler JM.  2014.  Activation of the vascular niche supports leukemic progression and resistance to chemotherapy.. Exp Hematol. 42(11):976-986.e3.
Guerrouahen BS, Pasquier J, Kaoud NAbu, Maleki M, Beauchamp M-C, Yasmeen A, Ghiabi P, Lis R, Vidal F, Saleh A et al..  2014.  Akt-activated endothelium constitutes the niche for residual disease and resistance to bevacizumab in ovarian cancer.. Mol Cancer Ther. 13(12):3123-36.
2011
Hormigo A, Ding B-S, Rafii S.  2011.  A target for antiangiogenic therapy: vascular endothelium derived from glioblastoma.. Proc Natl Acad Sci U S A. 108(11):4271-2.
2010
Butler JM, Kobayashi H, Rafii S.  2010.  Instructive role of the vascular niche in promoting tumour growth and tissue repair by angiocrine factors.. Nat Rev Cancer. 10(2):138-46.
2009
Ruan J, Hajjar K, Rafii S, Leonard JP.  2009.  Angiogenesis and antiangiogenic therapy in non-Hodgkin's lymphoma.. Ann Oncol. 20(3):413-24.
2002
Rafii S, Lyden D, Benezra R, Hattori K, Heissig B.  2002.  Vascular and haematopoietic stem cells: novel targets for anti-angiogenesis therapy? Nat Rev Cancer. 2(11):826-35.
2001
Choy M, Rafii S.  2001.  Role of angiogenesis in the progression and treatment of prostate cancer.. Cancer Invest. 19(2):181-91.